Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by Islandcron Apr 02, 2018 12:17pm
168 Views
Post# 27815050

RE:What if they dont get the licences??

RE:What if they dont get the licences??Pretty silly question really. There's a tremendous risk in investing in these kind of speculative stocks that depend on a cataylst like licencing being approved. All you can do if you are going to buy shares in companies is do DD and make sure you are investing in the best team possible that can secure a licence. The team they have put together at LIB is pretty solid and have engaged CCI and David Hyde who has a proven record of getting companies their HC approval. Huge upside in getting a licence or in this case two, but not being able to secure one obviously would be terrible for share price. Same thing goes for any pot company if something happens with the legalization process ie delays or rejection of the bill. All we can do is wait and see.
<< Previous
Bullboard Posts
Next >>